Immunogenicity of a recombinant yeast-derived hepatitis b vaccine

Home Page
About
Submit A Journal
Submit A Conference
Submit Paper/Book
- Submit a Preprint
- Submit a Book
Contact

Marmara Medical Journal
Volume:4 Issue:1
Immunogenicity of a recombinant yeast-derived hepatitis b vaccine

Immunogenicity of a recombinant yeast-derived hepatitis b vaccine

Authors : M Pamukçu, G Mutlu, G Yakupoğlu, G Süleymanlar, 0 Yeğin

Pages : 31-35

View : 9 | Download : 6

Publication Date : 1991-01-01

Article Type : Research Paper

Abstract :We examined the immunogcnicity and rcactigeni- city of a recombinant DNA yeast-derived hepatitis B vaccine in healthy adults. Thirty medical professionals who bad been working at the Akdcniz University Hospital were vaccinated with hepatitis B vaccine according to a 0,1, and 6 month vaccination schedule. One month after the third dose, seroconversion rate was 100% and all subjects had antibodies to hepatitis B surface antigen tilers in excess of 10IU / L. No serious adverse reactions attributable to the vaccine, were observed.
Keywords : Hepatitis B, prevention and control

ORIGINAL ARTICLE URL

VIEW PAPER (PDF)

* There may have been changes in the journal, article,conference, book, preprint etc. informations. Therefore, it would be appropriate to follow the information on the official page of the source. The information here is shared for informational purposes. IAD is not responsible for incorrect or missing information.